DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

Information source: St. Luke's Hospital, Chesterfield, Missouri
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Sleep; Memory

Intervention: zaleplon (Drug); zolpidem extended release (Drug); bedtime placebo (Drug); middle of the night placebo (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: St. Luke's Hospital, Chesterfield, Missouri

Official(s) and/or principal investigator(s):
Janine M Hall-Porter, PhD, Principal Investigator, Affiliation: St Luke's Hospital

Summary

The purpose of this study is to determine the effect of two hypnotic medications, zolpidem extended release and zaleplon, on memory. It is expected that a hypnotic with shorter drug duration will allow greater memory consolidation than a hypnotic with longer drug duration.

Clinical Details

Official title: Hypnotic Medications and Sleep-dependent Memory Consolidation: the Effect of Variable Drug Exposure During the Night

Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Basic Science

Primary outcome: Memory

Detailed description: A growing body of evidence has demonstrated that sleep promotes memory consolidation in healthy individuals. However, little research has been conducted regarding the effect of hypnotics on sleep-dependent memory. One study found that zopiclone (7. 5 mg), but not brotizolam (0. 25 mg), impaired sleep-dependent memory consolidation in normal sleepers. Another study reported significant impairment of sleep-dependent memory on a motor task with triazolam (0. 375 mg), but not with zolpidem immediate release (10 mg). These studies provide some evidence that sedative-hypnotic drugs may impair sleep-dependent memory consolidation, but further investigation is clearly needed in this area. Because hypnotics are commonly prescribed for insomnia, it is important to determine if there is a significant risk of impairment in sleep-dependent memory consolidation associated with these medications. Further, investigation of alternative doses and drug regimens upon memory consolidation appears warranted. The purpose of the current study is to determine the effect of two hypnotic medications on sleep-dependent memory consolidation in normal sleepers. Zolpidem extended release, which will be active for most of the sleep period when administered at bedtime, will be compared to zaleplon, which will be active for half of the sleep period when administered in the middle of the night. This comparison allows us to address the question of whether a few hours of drug-free sleep results in better memory consolidation than sleep with drug throughout the night.

Eligibility

Minimum age: 18 Years. Maximum age: 50 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 18 to 50 years of age

- no sleep complaints or problems

- good sleep quality per questionnaire

- sufficient time in bed each night

Exclusion Criteria:

- any clinically significant unstable medical condition

- recent psychiatric disorder

- prior diagnosis or symptoms of a sleep disorder

- recent history of substance abuse

- recent use of prescription hypnotic medication or over-the-counter sleep aid

- recent use of psychotropic medication

- history of adverse reaction to benzodiazepines

- body mass index > 36

- currently pregnant or nursing

- currently working rotating or night shift

- consumption of > 700 mg per day of xanthine-containing food or beverages

- consumption of > 14 units of alcohol per week

- smoke > 1 pack of cigarettes per day, use of chewing tobacco more than 3 times per

day, or unable to refrain from smoking or chewing without distress or discomfort while in the sleep laboratory

Locations and Contacts

St. Luke's Hospital Sleep Medicine and Research Center, Chesterfield, Missouri 63017, United States
Additional Information

Related publications:

Greenblatt DJ, Harmatz JS, von Moltke LL, Ehrenberg BL, Harrel L, Corbett K, Counihan M, Graf JA, Darwish M, Mertzanis P, Martin PT, Cevallos WH, Shader RI. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther. 1998 Nov;64(5):553-61.

Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance. Fundam Clin Pharmacol. 2006 Aug;20(4):397-403.

Starting date: October 2010
Last updated: August 25, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017